Sands Capital Ventures »

Odyssey Therapeutics shares owned by Sands Capital Ventures

Quarter-by-quarter ownership of Odyssey Therapeutics shares owned by Sands Capital Ventures from 13F filings

Historical chart of Sands Capital Ventures investment in Odyssey Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Odyssey Therapeutics held by Sands Capital Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Odyssey Therapeutics by Sands Capital Ventures

Quarter filed Position value Share count Share price at filing
2026-06-30 $16M 875k 18.71

More positions owned by Sands Capital Ventures

Alamar Biosciences Common Stock
Nu Hldgs Ord Shs Cl A (NU)
Klaviyo Com Ser A (KVYO)
Beta Bionics (BBNX)
Spyglass Pharma Com Shs (SGP)
Inhibikase Therapeutics Com New (IKT)
Doordash Cl A (DASH)
Coupang Cl A (CPNG)
Datadog Cl A Com (DDOG)
Bioage Labs (BIOA)
10x Genomics Cl A Com (TXG)
Samsara Com Cl A (IOT)
Odyssey Therapeutics Common Stock
Toast Cl A (TOST)
Acumen Pharmaceuticals (ABOS)

View all positions for Sands Capital Ventures

Top funds holding Odyssey Therapeutics

FMR
Sr One Capital Management
Lightspeed Management Company
OrbiMed Advisors
Sanofi
Deerfield Management Company
Sands Capital Ventures
Hillhouse Capital Advisors
General Catalyst Group Management
Affinity Asset Advisors
Adage Capital Partners GP
Vanguard Capital Management
Foresite Capital Management V
Vivo Capital
EcoR1 Capital

View all funds holding Odyssey Therapeutics